PD-L1 expression was observed in approximatively 50% and 94% of tumor cells and immune cells in the EBV subtype and in approximatively 33% and 45% of tumor cells and immune cells in MSI-H tumors [33]. This evidence concerns the gene CD274 and neoplasm.